Schering-Plough
SGP
#532
Rank
ยฃ34.48 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: ยฃ13.81 Billion

In 2008 the company made a revenue of ยฃ13.81 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008ยฃ13.81 B
2006ยฃ7.90 B11.42%
2005ยฃ7.09 B14.94%
2004ยฃ6.17 B-0.74%
2003ยฃ6.22 B-18.13%
2002ยฃ7.59 B3.86%
2001ยฃ7.31 B-0.13%
2000ยฃ7.32 B6.96%
1999ยฃ6.85 B13.61%
1998ยฃ6.02 B19.16%
1997ยฃ5.06 B19.84%
1996ยฃ4.22 B